Evidence map›Paper›PMID 28337208›Full record

ArticleFrontiers in immunology2017

Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin

Federica Bozzano, Francesco Marras, Andrea De Maria

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. βBrain, behavior, and immunity · 2018
    Trial
  2. Review
  3. Article
  4. Article
  5. Decidual CXCR4Clinical and translational medicine · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Federica BozzanoDepartment of Experimental Medicine (DIMES), University of Genova, Genova, Italy; Center of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy.
Francesco MarrasIstituto Giannina Gaslini , Genova , Italy.
Andrea De MariaCenter of Excellence for Biomedical Research (CEBR), University of Genova, Genova, Italy; Clinica Malattie Infettive, IRCCS AOU San Martino-IST Genova, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy; Department of Health Sciences, DISSAL, University of Genova, Genova, Italy.
University of Genoa · ITIstituto Giannina Gaslini · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the first description of natural killer (NK) cells, the view on their role in innate immunity has evolved considerably. In addition to first-line defense against transformed and pathogen-infected autologous cells, NK cells contribute to modulate adaptive immune responses and in some cases acquire specialized functions, including exhausted, adaptive, and decidual NK cells. NK cells derive from CD34

Indexed as

CD34common lymphoid progenitorsDNAM-1natural killerNK cell development

Identifiers

PMID28337208
PMCPMC5343008
OpenAlexW2593206475

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.